Dyne Therapeutics, Inc. (DYN) Ownership

$13.54

north_east
$0.08 (0.59%)
Day's range
$13.33
Day's range
$13.97

Dyne Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 11/13/2024 9.03 M $324.24 M   69.71% 8.95%
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC 11/13/2024 8.02 M $288.08 M   0.00% 7.95%
BLACKROCK FUNDING, INC. /DE 11/13/2024 7.79 M $279.96 M   100.00% 7.73%
VANGUARD GROUP INC 11/13/2024 6.86 M $246.56 M   45.49% 6.80%
RTW INVESTMENTS, LP 11/14/2024 6.82 M $244.93 M   6.76% 6.76%
JANUS HENDERSON GROUP PLC 11/14/2024 6.81 M $244.76 M   47.35% 6.75%
RA CAPITAL MANAGEMENT, L.P. 11/14/2024 6.38 M $229.21 M   5.49% 6.33%
FCPM III SERVICES B.V. 11/14/2024 5.95 M $213.87 M   -24.11% 5.90%
STATE STREET CORP 11/14/2024 3.64 M $130.82 M   13.77% 3.61%
DEEP TRACK CAPITAL, LP 11/14/2024 3.28 M $117.89 M   -17.95% 3.25%
CITADEL ADVISORS LLC 11/14/2024 2.94 M $105.58 M   -31.90% 2.91%
TCG CROSSOVER MANAGEMENT, LLC 11/14/2024 2.65 M $95.19 M   0.00% 2.63%
PRICE T ROWE ASSOCIATES INC /MD/ 11/14/2024 2.64 M $94.70 M   11.42% 2.61%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2024 2.40 M $86.31 M   -27.80% 2.38%
VR ADVISER, LLC 11/14/2024 2.17 M $78.09 M   0.00% 2.15%
HOLOCENE ADVISORS, LP 11/14/2024 1.98 M $71.22 M   -4.51% 1.97%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 1.86 M $66.80 M   4.78% 1.84%
JENNISON ASSOCIATES LLC 11/08/2024 1.35 M $48.38 M   1.49% 1.34%
FRANKLIN RESOURCES INC 11/27/2024 1.34 M $44.72 M   -21.70% 1.33%
FIRST LIGHT ASSET MANAGEMENT, LLC 11/14/2024 1.26 M $45.16 M   228.76% 1.25%
ARMISTICE CAPITAL, LLC 11/14/2024 1.16 M $41.49 M   18.98% 1.15%
SIREN, L.L.C. 11/13/2024 1.13 M $40.76 B   100.00% 1.12%
VIVO CAPITAL, LLC 11/13/2024 1.11 M $40.05 M   -31.81% 1.11%
MORGAN STANLEY 11/14/2024 1.05 M $37.83 M   88.40% 1.04%
WOODLINE PARTNERS LP 11/14/2024 977,440 $35.11 M   -20.79% 0.97%
ARROWMARK COLORADO HOLDINGS LLC 11/14/2024 900,190 $32.33 M   -2.09% 0.89%
SOFINNOVA INVESTMENTS, INC. 11/13/2024 772,070 $27.73 B   -52.51% 0.77%
NORTHERN TRUST CORP 11/13/2024 721,502 $25.92 M   16.44% 0.72%
MAN GROUP PLC 11/14/2024 718,650 $25.81 M   100.00% 0.71%
PERCEPTIVE ADVISORS LLC 11/14/2024 718,144 $25.80 M   100.00% 0.71%
ORBIMED ADVISORS LLC 11/14/2024 708,400 $25.45 M   0.00% 0.70%
MPM ASSET MANAGEMENT LLC 11/13/2024 682,376 $24.51 M   -56.30% 0.68%
BAKER BROS. ADVISORS LP 11/14/2024 672,096 $24.14 M   0.00% 0.67%
GOLDMAN SACHS GROUP INC 11/14/2024 670,484 $24.08 M   -68.01% 0.66%
AVORO CAPITAL ADVISORS LLC 11/14/2024 650,000 $23.35 M   461.55% 0.64%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 648,652 $23.30 M   7.92% 0.64%
UBS GROUP AG 11/14/2024 625,719 $22.48 M   156.52% 0.62%
ECOR1 CAPITAL, LLC 11/14/2024 555,644 $19.96 M   30.12% 0.55%
ROCK SPRINGS CAPITAL MANAGEMENT LP 11/14/2024 461,028 $16.56 M   0.00% 0.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11/14/2024 435,653 $15.65 M   100.00% 0.43%
FARALLON CAPITAL MANAGEMENT LLC 11/14/2024 428,000 $15.37 M   7,033.33% 0.42%
VIDA VENTURES ADVISORS, LLC 10/08/2024 407,499 $14.64 M   0.00% 0.40%
CANDRIAM S.C.A. 11/13/2024 390,956 $14.04 M   -26.69% 0.39%
EVENTIDE ASSET MANAGEMENT, LLC 11/14/2024 332,277 $11.94 M   -31.49% 0.33%
WASATCH ADVISORS LP 11/14/2024 324,099 $11.64 M   -3.43% 0.32%
ENSIGN PEAK ADVISORS, INC 11/14/2024 312,752 $11.23 M   0.00% 0.31%
PICTET ASSET MANAGEMENT HOLDING SA 11/12/2024 304,705 $10.32 M   3.38% 0.30%
BANK OF AMERICA CORP /DE/ 11/14/2024 291,712 $10.48 M   65.02% 0.29%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 276,414 $9.93 M   -56.38% 0.27%
OCTAGON CAPITAL ADVISORS LP 11/14/2024 262,726 $9.44 M   -77.75% 0.26%

Dyne Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 233 institutional investors and hedge funds held shares of Dyne Therapeutics, Inc.. The most heavily invested institutionals were:

JENNISON ASSOCIATES LLC: 1.21 M

Vida Ventures Advisors, LLC: 407,499

abrdn plc: 25,803

KBC Group NV: 3,135

GPS Wealth Strategies Group, LLC: 400

Spire Wealth Management: 300

111.02% of Dyne Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 118.14 M shares in the last 24 months. This purchase volume represents approximately $1.60 B in transactions.